Atara Biotherapeutics, Inc. (ATRA) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 12.17M | 12.21M | 18.43M | 24.77M | 27.18M | 64.89M | 91.86M | 62.41M | 106.43M | 101.87M | 118.7M | 172.32M |
| Cash & Short-Term Investments | 8.36M | 8.48M | 13.71M | 22.32M | 13.84M | 42.5M | 67.19M | 35.29M | 46.24M | 51.73M | 102.41M | 153.64M |
| Cash Only | 8.36M | 8.48M | 5.74M | 16.9M | 13.84M | 25.03M | 46.45M | 31.31M | 35.09M | 25.84M | 64.79M | 45.9M |
| Short-Term Investments | 0 | 0 | 7.97M | 5.42M | 0 | 17.47M | 20.74M | 3.98M | 11.15M | 25.88M | 37.62M | 107.74M |
| Accounts Receivable | 0 | 1.25M | 1.91M | 0 | 8.88M | 1.48M | 1.33M | 2.42M | 35.83M | 34.11M | 163K | 507K |
| Days Sales Outstanding | - | 91.31 | 50.97 | - | 4.75 | 3.96 | 4.3 | 60.78 | 116.33 | 370.76 | 14.42 | 42.98 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 10.65M | 13.98M | 18.75M | 16.08M | 9.71M | 6.59M | 7.86M |
| Days Inventory Outstanding | - | - | - | - | - | 166.77 | 198.04 | 342.53 | 591.16 | 237.23 | 254.22 | 207.48 |
| Other Current Assets | 3.81M | 2.48M | 2.81M | 2.45M | 4.47M | 10.26M | 9.35M | 5.95M | 8.28M | 6.33M | 9.53M | 10.31M |
| Total Non-Current Assets | 7.82M | 8.02M | 11.73M | 12.13M | 34.86M | 44.2M | 50.85M | 54.87M | 58.84M | 63.63M | 70.09M | 74.12M |
| Property, Plant & Equipment | 6.93M | 7.14M | 10.85M | 11.2M | 32.01M | 41.1M | 47.49M | 51.27M | 54.97M | 58.79M | 63.8M | 67.54M |
| Fixed Asset Turnover | 0.07x | 0.18x | 0.31x | 0.81x | 2.68x | 0.74x | 0.81x | 0.54x | 0.48x | 0.07x | 0.03x | 0.01x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 890K | 886K | 881K | 927K | 2.84M | 3.1M | 3.36M | 3.61M | 3.87M | 4.84M | 6.29M | 6.58M |
| Total Assets | 20M | 20.23M | 30.17M | 36.9M | 62.04M | 109.1M | 142.71M | 117.28M | 165.27M | 165.5M | 188.79M | 246.44M |
| Asset Turnover | 0.03x | 0.06x | 0.10x | 0.36x | 1.15x | 0.26x | 0.31x | 0.20x | 0.17x | 0.02x | 0.01x | 0.00x |
| Asset Growth % | -67.77% | -81.45% | -78.86% | -68.54% | -62.46% | -34.08% | -24.41% | -52.41% | -45.29% | -56.03% | -48.74% | -43.49% |
| Total Current Liabilities | 5.64M | 14.92M | 18.06M | 14.56M | 47.89M | 134.57M | 155.98M | 148.27M | 180.69M | 142.23M | 79.09M | 74.55M |
| Accounts Payable | 637K | 127K | 318K | 1.76M | 1.38M | 4.37M | 2.15M | 5.25M | 2.85M | 3.68M | 6.51M | 4.14M |
| Days Payables Outstanding | 277.26 | 196.83 | 832 | 258.38 | 12.66 | 44.09 | 44.77 | 79.72 | 149.86 | 148.41 | 187.32 | 144.69 |
| Short-Term Debt | 0 | 10.78M | 11.62M | 0 | 14.4M | 0 | 15.25M | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 684K | 716K | 1.01M | 1.61M | 15.98M | 95.09M | 116.34M | 107.58M | 123.15M | 77.83M | 11.61M | 11.95M |
| Other Current Liabilities | 4.32M | 3.3M | 3.04M | 2.55M | 2.2M | 6.59M | -187K | 7.27M | 5.71M | 37.01M | 14.43M | 12.56M |
| Current Ratio | 2.16x | 0.82x | 1.02x | 1.70x | 0.57x | 0.48x | 0.59x | 0.42x | 0.59x | 0.72x | 1.50x | 2.31x |
| Quick Ratio | 2.16x | 0.82x | 1.02x | 1.70x | 0.57x | 0.40x | 0.50x | 0.29x | 0.50x | 0.65x | 1.42x | 2.21x |
| Cash Conversion Cycle | - | - | - | - | - | 126.64 | 157.57 | 323.59 | 557.62 | 459.59 | 81.31 | 105.77 |
| Total Non-Current Liabilities | 51.66M | 43.81M | 48.74M | 57.38M | 69.22M | 71.81M | 77.27M | 79.89M | 82.89M | 122.51M | 160.54M | 164.43M |
| Long-Term Debt | 9.08M | 32.67M | 31.98M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 9.35M | 15.01M | 15.43M | 26.71M | 29.91M | 35.24M | 38.7M | 42.2M | 45.69M | 48.51M | 51.75M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 42.59M | 1.79M | 1.76M | 41.95M | 42.51M | 41.89M | 41.55M | 40.62M | 39.97M | 39.25M | 38.1M | 37.11M |
| Total Liabilities | 57.31M | 58.74M | 66.8M | 71.94M | 117.11M | 206.38M | 233.25M | 228.15M | 263.58M | 264.74M | 239.63M | 238.99M |
| Total Debt | 9.08M | 52.8M | 58.6M | 17.67M | 55.03M | 43.83M | 65.15M | 52.7M | 56.23M | 57.87M | 61.8M | 64.71M |
| Net Debt | 716K | 44.32M | 52.86M | 765K | 41.19M | 18.8M | 18.7M | 21.39M | 21.14M | 32.03M | -2.99M | 18.81M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | 8.68x |
| Debt / EBITDA | - | - | - | 5.15x | 1.36x | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | 0.22x | 1.01x | - | - | - | - | - | - | - |
| Interest Coverage | -4.06x | -2.81x | -3.70x | 3.46x | 38.37x | -11.50x | -17.53x | -14.09x | -26.52x | -50.39x | -49.05x | -50.60x |
| Total Equity | -37.31M | -38.5M | -36.63M | -35.04M | -55.07M | -97.28M | -90.54M | -110.87M | -98.31M | -99.23M | -50.84M | 7.45M |
| Equity Growth % | 32.25% | 60.42% | 59.54% | 68.39% | 43.98% | 1.96% | -78.09% | -1587.36% | -251.34% | -178.36% | -127.17% | -97.1% |
| Book Value per Share | -2.65 | -3.03 | -2.70 | -2.85 | -5.08 | -9.10 | -12.13 | -18.05 | -17.48 | -22.94 | -11.94 | 1.77 |
| Total Shareholders' Equity | -37.31M | -38.5M | -36.63M | -35.04M | -55.07M | -97.28M | -90.54M | -110.87M | -98.31M | -99.23M | -50.84M | 7.45M |
| Common Stock | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 0 | 12K | 11K | 10K | 10K |
| Retained Earnings | -2.03B | -2.02B | -2.02B | -2.01B | -2.02B | -2.05B | -2.04B | -2.02B | -2B | -1.97B | -1.91B | -1.84B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 1K | 2K | 0 | 0 | 8K | 22K | -14K | -55K | -204K | -571K | -933K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |